Cases & Deals

Sunesis Pharmaceuticals successfully prosecutes U.S. patent for vosaroxin

Clients Sunesis Pharmaceuticals, Inc.

On behalf of Sunesis Pharmaceuticals, Inc., Jones Day successfully prosecuted a U.S. patent application for vosaroxin which is used in the treatment of leukemia. The patent issued as United States Patent No. 7,989,468.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.